FDA
approval
· 2022-04-22
FDA Approved: LUPRON DEPOT-PED — Supplemental Application (AbbVie Inc.)
Summary
The FDA approved a supplemental application for LUPRON DEPOT-PED (Leuprolide acetate) from AbbVie Inc., supporting its pediatric use. This represents a suppleme…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LUPRON DEPOT-PED (LEUPROLIDE ACETATE)